newsfilter
← Latest News
PR Newswire·

BioVaxys Announces Uplisting To The OCTQB Venture Market

VANCOUVER, BC, May 19, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV), (FRA: 5LB), (OTCQB:BVAXF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancer applications, is pleased to announce that it is has been u